Header Logo

Connection

Lawrence Kushi to California

Back to Details
This is a "connection" page, showing publications Lawrence Kushi has written about California.
Lawrence Kushi
Connection Strength
2.307
California
  1. Differences in breast cancer survival across Asian American ethnicities compared with non-Latina White females in Kaiser Permanente Northern California. J Natl Cancer Inst. 2026 Jul 01; 118(7):1266-1277.
    View in: PubMed
    Score: 0.150
  2. Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
    View in: PubMed
    Score: 0.134
  3. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system. Gynecol Oncol. 2020 10; 159(1):221-228.
    View in: PubMed
    Score: 0.100
  4. Environmental Tobacco Smoke Exposure in Relation to Family Characteristics, Stressors and Chemical Co-Exposures in California Girls. Int J Environ Res Public Health. 2019 10 30; 16(21).
    View in: PubMed
    Score: 0.095
  5. Neighborhood deprivation, race/ethnicity, and urinary metal concentrations among young girls in California. Environ Int. 2016 May; 91:29-39.
    View in: PubMed
    Score: 0.073
  6. Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
    View in: PubMed
    Score: 0.071
  7. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. JAMA Oncol. 2015 Sep; 1(6):737-45.
    View in: PubMed
    Score: 0.071
  8. Brominated Flame Retardants and Other Persistent Organohalogenated Compounds in Relation to Timing of Puberty in a Longitudinal Study of Girls. Environ Health Perspect. 2015 Oct; 123(10):1046-52.
    View in: PubMed
    Score: 0.069
  9. Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. J Oncol Pract. 2015 01; 11(1):e1-8.
    View in: PubMed
    Score: 0.066
  10. Maternal hyperglycemia during pregnancy predicts adiposity of the offspring. Diabetes Care. 2014 Nov; 37(11):2996-3002.
    View in: PubMed
    Score: 0.066
  11. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
    View in: PubMed
    Score: 0.065
  12. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
    View in: PubMed
    Score: 0.057
  13. The prevalence of obesity and obesity-related health conditions in a large, multiethnic cohort of young adults in California. Ann Epidemiol. 2012 Sep; 22(9):609-16.
    View in: PubMed
    Score: 0.057
  14. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.052
  15. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.051
  16. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.048
  17. Body burdens of brominated flame retardants and other persistent organo-halogenated compounds and their descriptors in US girls. Environ Res. 2010 Apr; 110(3):251-7.
    View in: PubMed
    Score: 0.048
  18. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.043
  19. Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast?cancer. J Natl Cancer Inst. 2026 Jul 01; 118(7):1278-1289.
    View in: PubMed
    Score: 0.038
  20. Breast Cancer Survival in Asian American Patients. JAMA Netw Open. 2026 Jul 01; 9(7):e2621041.
    View in: PubMed
    Score: 0.038
  21. Tailored Exercise Strategies and Mortality Among Breast Cancer Survivors. JAMA Netw Open. 2026 04 01; 9(4):e265177.
    View in: PubMed
    Score: 0.037
  22. The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer. Cancer. 2026 Mar 15; 132(6):e70318.
    View in: PubMed
    Score: 0.037
  23. Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer. J Natl Cancer Inst. 2026 Feb 01; 118(2):307-315.
    View in: PubMed
    Score: 0.037
  24. Disparities in cardiometabolic and cardiovascular risk after breast cancer: the Pathways Heart Study. JNCI Cancer Spectr. 2026 Jan 09; 10(1).
    View in: PubMed
    Score: 0.036
  25. Metastatic Recurrence Among Adolescents and Young Adults With Cancer. JAMA Oncol. 2026 01 01; 12(1):75-83.
    View in: PubMed
    Score: 0.036
  26. Identifying Patterns of Late Effects With Latent Class Analysis Among Adolescent and Young Adult Thyroid Cancer Survivors in California and Utah. Cancer Med. 2025 Dec; 14(23):e71316.
    View in: PubMed
    Score: 0.036
  27. Identifying clustering in patterns of late effects among survivors of adolescent and young adult Hodgkin lymphoma. JNCI Cancer Spectr. 2025 Nov 03; 9(6).
    View in: PubMed
    Score: 0.036
  28. Incidence of chronic medical conditions among survivors of adolescent and young adult cancer compared to a population without cancer. Cancer. 2025 Oct 15; 131(20):e70125.
    View in: PubMed
    Score: 0.036
  29. Evaluation of the Electronic Health Record-Support Social Support Score in Breast Cancer: Comparison of Count and Item Response Theory Scores. Popul Health Manag. 2025 12; 28(6):273-280.
    View in: PubMed
    Score: 0.036
  30. Trastuzumab therapy and new-onset hypertension in adolescents and young adults with breast cancer. Breast Cancer Res Treat. 2025 Aug; 213(1):81-92.
    View in: PubMed
    Score: 0.035
  31. Preferred and Actual Location of Death in Adolescents and Young Adults With Cancer. JAMA Netw Open. 2025 Jan 02; 8(1):e2454000.
    View in: PubMed
    Score: 0.034
  32. Evolution in Documented Goals of Care at End of Life for Adolescents and Younger Adults With Cancer. JAMA Netw Open. 2024 Dec 02; 7(12):e2450489.
    View in: PubMed
    Score: 0.034
  33. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system. Breast Cancer Res Treat. 2024 Nov; 208(2):405-414.
    View in: PubMed
    Score: 0.033
  34. Pubertal Timing Across Asian American, Native Hawaiian, and Pacific Islander Subgroups. JAMA Netw Open. 2024 May 01; 7(5):e2410253.
    View in: PubMed
    Score: 0.032
  35. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
    View in: PubMed
    Score: 0.024
  36. Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area. Int J Hyg Environ Health. 2019 08; 222(7):1038-1046.
    View in: PubMed
    Score: 0.023
  37. Longitudinal study of age of menarche in association with childhood concentrations of persistent organic pollutants. Environ Res. 2019 09; 176:108551.
    View in: PubMed
    Score: 0.023
  38. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
    View in: PubMed
    Score: 0.022
  39. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.021
  40. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
    View in: PubMed
    Score: 0.020
  41. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.020
  42. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.020
  43. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
    View in: PubMed
    Score: 0.020
  44. Associations of urinary phthalate and phenol biomarkers with menarche in a multiethnic cohort of young girls. Reprod Toxicol. 2017 01; 67:56-64.
    View in: PubMed
    Score: 0.019
  45. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
    View in: PubMed
    Score: 0.019
  46. Thyroid Hormones and Timing of Pubertal Onset in a Longitudinal Cohort of Females, Northern California, 2006-11. Paediatr Perinat Epidemiol. 2016 May; 30(3):285-93.
    View in: PubMed
    Score: 0.018
  47. Thyroid Antagonists (Perchlorate, Thiocyanate, and Nitrate) and Childhood Growth in a Longitudinal Study of U.S. Girls. Environ Health Perspect. 2016 Apr; 124(4):542-9.
    View in: PubMed
    Score: 0.018
  48. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.017
  49. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.016
  50. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
    View in: PubMed
    Score: 0.015
  51. Does neighborhood environment influence girls' pubertal onset? findings from a cohort study. BMC Pediatr. 2012 Mar 13; 12:27.
    View in: PubMed
    Score: 0.014
  52. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17.
    View in: PubMed
    Score: 0.013
  53. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.013
  54. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.013
  55. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010 Sep 20; 28(27):4120-8.
    View in: PubMed
    Score: 0.012
  56. Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspect. 2010 Jul; 118(7):1039-46.
    View in: PubMed
    Score: 0.012
  57. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
    View in: PubMed
    Score: 0.011
  58. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect. 2007 Jan; 115(1):116-21.
    View in: PubMed
    Score: 0.010
  59. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006 Nov 20; 24(33):e49-50.
    View in: PubMed
    Score: 0.010

© 2026 Kaiser Permanente

Your Privacy Choices